O'Leary Leslie A, Ortiz Linnette, Montgomery April, Fox Deborah J, Cunniff Christopher, Ruttenber Margaret, Breen April, Pettygrove Sydney, Klumb Don, Druschel Charlotte, Frías Jaime L, Robinson Luther K, Bertrand Jacquelyn, Ferrara Kelly, Kelly Maureen, Gilboa Suzanne M, Meaney F John
Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia.
Birth Defects Res A Clin Mol Teratol. 2015 Mar;103(3):196-202. doi: 10.1002/bdra.23335. Epub 2015 Mar 12.
Surveillance of fetal alcohol syndrome (FAS) is important for monitoring the effects of prenatal alcohol exposure and describing the public health burden of this preventable disorder. Building on the infrastructure of the Fetal Alcohol Syndrome Surveillance Network (FASSNet, 1997-2002), in 2009 the Centers for Disease Control and Prevention awarded 5-year cooperative agreements to three states, Arizona, Colorado, and New York, to conduct population-based surveillance of FAS. The Fetal Alcohol Syndrome Surveillance Network II (FASSNetII, 2009-2014) developed a surveillance case definition based on three clinical criteria: characteristic facial features, central nervous system abnormalities, and growth deficiency. FASSNetII modified the FASSNet methods in three important ways: (1) estimation of a period prevalence rather than birth prevalence; (2) surveillance of FAS among school-age children (ages 7-9 years) to better document the central nervous system abnormalities that are not apparent at birth or during infancy; and (3) implementation of an expert clinical review of abstracted data for probable and confirmed cases classified through a computerized algorithm. FASSNetII abstracted data from multiple sources including birth records, medical records from child development centers or other specialty clinics, and administrative databases such as hospital discharge and Medicaid. One challenge of FASSNetII was its limited access to non-medical records. The FAS prevalence that could be estimated was that of the population identified through an encounter with the healthcare system. Clinical and public health programs that identify children affected by FAS provide critical information for targeting preventive, medical and educational services in this vulnerable population.
胎儿酒精谱系障碍(FAS)监测对于监控产前酒精暴露的影响以及描述这种可预防疾病的公共卫生负担至关重要。在胎儿酒精谱系障碍监测网络(FASSNet,1997 - 2002年)的基础设施基础上,2009年美国疾病控制与预防中心向亚利桑那州、科罗拉多州和纽约州这三个州授予了为期5年的合作协议,以开展基于人群的FAS监测。胎儿酒精谱系障碍监测网络二期(FASSNetII,2009 - 2014年)基于三个临床标准制定了监测病例定义:特征性面部特征、中枢神经系统异常和生长发育迟缓。FASSNetII在三个重要方面对FASSNet方法进行了修改:(1)估计期间患病率而非出生患病率;(2)对学龄儿童(7 - 9岁)进行FAS监测,以更好地记录出生时或婴儿期不明显的中枢神经系统异常;(3)对通过计算机算法分类的可能病例和确诊病例的抽象数据进行专家临床审查。FASSNetII从多个来源提取数据,包括出生记录、儿童发育中心或其他专科诊所的医疗记录以及医院出院和医疗补助等行政数据库。FASSNetII面临的一个挑战是获取非医疗记录的机会有限。能够估计的FAS患病率是通过医疗保健系统接触确定的人群的患病率。识别受FAS影响儿童的临床和公共卫生项目为针对这一弱势群体的预防、医疗和教育服务提供了关键信息。